Name: MapLight Therapeutics, Inc. (MPLT) Balance Sheet
Creator: FinSpry

MapLight Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for MapLight Therapeutics, Inc. (MPLT) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	38.25	79.77	27.67
Short-Term Investments	70.54	0.00	0.00
Cash & Short-Term Investments	108.80	79.77	27.67
Accounts Receivable	0.00	0.00	0.00
Inventory	0.00	0.00	0.00
Other Current Assets	5.81	3.84	4.37
Total Current Assets	114.60	83.60	32.03
Non-Current Assets
Property, Plant & Equipment (Net)	7.56	6.59	7.12
Long-Term Investments	11.59	0.99	0.00
Other Non-Current Assets	3.17	0.23	0.23
Total Non-Current Assets	22.31	0.00	0.00
Total Assets	136.92	91.41	39.39
Current Liabilities
Accounts Payable	1.91	3.25	3.60
Short-Term Debt	0.78	0.00	0.00
Accrued Liabilities	9.99	6.76	2.79
Deferred Revenue	3.24	4.20	5.86
Other Current Liabilities	9.99	0.00	0.00
Total Current Liabilities	15.92	14.70	12.60
Non-Current Liabilities
Long-Term Debt	5.80	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00
Total Non-Current Liabilities	5.80	0.00	0.00
Total Liabilities	21.72	20.13	18.52
Stockholders' Equity
Retained Earnings	-199.37	-121.79	-66.08
Accumulated Other Comprehensive Income	0.16	0.00	0.00
Total Stockholders' Equity	115.20	71.28	20.87
Total Liabilities & Equity	136.92	0.00	0.00